Eszopiclone didn't enhance tumors in the p53 transgenic mouse bioassay at oral doses approximately three hundred mg/kg/working day. Mutagenesis Eszopiclone was clastogenic in in vitro (mouse lymphoma and chromosomal aberration) assays in mammalian cells. Eszopiclone was destructive from the in vitro bacterial gene mutation (Ames) assay As well as in https://pennt641kry7.myparisblog.com/profile